MU
Michael Ulz Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
26%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
70%
Neutral
30%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $25 |
217%
upside
| 1 | +141% |
0
%
| 4 Dec ‘25 9 hours ago |
|
|
|
Equal-Weight
Maintained
| $48 |
26%
downside
| 2 | – |
–
| 26 Nov ‘25 8 days ago |
|
|
|
Overweight
Maintained
| $94 |
15%
upside
| 3 | +18% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $102 |
162%
upside
| 1 | +23% |
0
%
| 23 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $81 |
13%
upside
| 1 | -5.9% |
0
%
| 16 Oct ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $21 |
257%
upside
| 1 | -1.3% |
0
%
| 9 Oct ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $475 |
2%
upside
| 1 | – |
–
| 6 Oct ‘25 1 month ago |
|